Catalyst Wire Dossier Catalyst Wire Dossier

AndexXa

andexanet alfa · Alexion Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AndexXa, covering 2024-07-03 to 2024-07-03. Get the full timeline:

Most recent: Clinical Trial Update: Trial of Andexanet Alfa in ICrH Patients Receiving an Oral FXa Inhibitor [Phase 4]

See pricing